首页> 外文期刊>Turkish Journal of Endocrinology and Metabolism >Characteristics of Acromegaly Patients Followed at a Single Center
【24h】

Characteristics of Acromegaly Patients Followed at a Single Center

机译:单个中心接受肢端肥大症患者的特征

获取原文
           

摘要

Introduction: Acromegaly is a chronic condition with a three to four fold higher rate of mortality than general population. if remain untreated. Acromegaly has an estimated prevalence of 40 cases per million population and an annual incidence of three to seven cases per million population. Early diagnosis and treatment of this disease is of great importance since it affects many organs and systems. So. we retrospectively investigated the characteristics of acromegaly patients to assess their clinical and follow-up status. Patients and Methods: Clinical and laboratory records of 32 acromegaly patients (mean age = 53.8±10.5 SD; 19 female. 13 male) were analysed. The mean follow-up period of the patients was 39±25 months. Only 6 of the patients had transsphenoidal (TS) pituitary surgery in our center. The mean IGF-1 values before and after pituiary surgery were 745±302 and 284±177 ng/mL. respectively. Four patients were treated with long acting somatostatin analogs (SS-RA) as primary therapy while the remaining patients underwent pituitary surgery. Six patients were cured after first surgery and 16 were treated with SS-RA. Five patients lost to follow-up after surgery and 5 patients continued their treatment in other centers. Cure was achieved in 3 patients who were operated in our center and 3 patients received SS-RA therapy. Among 16 patients who were treated with SS-RA's. pegvisomant was added to 2 patients. due to the lack of response to SS-RA's. Conclusion: The treatment and follow-up of patients with acromegaly should be carried out in centers consisted of a team of experienced neurosergeons and endocrinologists regarding the the treatment of acromegaly. Although our university and medical faculty are newly established. The number of patients with acromaly is increased day by day and tough the neurosergeons in our center are trained in pitutary surgery. the number of surgeries carried out in our center are not enough to boost their experience. Therefore. the team of neurosurgeons in our center are constantly involved in various educational events. in order to improve their experience in pituitary surgery.
机译:简介:肢端肥大症是一种慢性疾病,死亡率比普通人群高三到四倍。如果不予治疗。肢端肥大症的患病率估计为每百万人口40例,每百万人口每年3至7例。这种疾病的早期诊断和治疗非常重要,因为它会影响许多器官和系统。所以。我们回顾性调查了肢端肥大症患者的特征,以评估其临床和随访状况。患者与方法:分析了32例肢端肥大症患者的临床和实验室记录(平均年龄= 53.8±10.5 SD; 19例女性。13例男性)。患者的平均随访期为39±25个月。在我们中心,只有6例患者进行了蝶窦垂体手术。垂体手术前后的平均IGF-1值为745±302和284±177 ng / mL。分别。四名患者接受长效生长抑素类似物(SS-RA)治疗作为主要疗法,其余患者则进行了垂体手术。首次手术后治愈了6例患者,使用SS-RA治疗了16例。手术后有5名患者失去随访,另有5名患者在其他中心继续接受治疗。在我们中心接受手术的3例患者中治愈,3例接受SS-RA治疗。在接受SS-RA治疗的16例患者中。培维索孟加至2例患者。由于缺乏对SS-RA的回应。结论:肢端肥大症的治疗和随访应在由经验丰富的神经元和内分泌专家组成的中心进行有关肢端肥大症的治疗。虽然我们的大学和医学院是新成立的。肩峰症患者的人数每天都在增加,并且我们中心的神经中枢在垂体手术方面接受了严格的培训。我们中心进行的手术数量不足以增加他们的经验。因此。我们中心的神经外科医生团队不断参与各种教育活动。为了提高他们的垂体手术经验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号